US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco S&P 500 Equal Weight Health Care ETF

37.84

+0.37000.99%

Post-market: 37.80-0.0400-0.11%19:58 EDT

Volume:518.06K

Turnover:19.62M

Market Cap:841.94M

PE:- -

High:38.02

Open:37.52

Low:37.52

Close:37.47

52wk High:38.19

52wk Low:28.26

Shares:22.25M

Float Shares:22.25M

Volume Ratio:2.32

T/O Rate:2.33%

Dividend:0.23

Dividend Rate:0.61%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Elevance Plans to Exit More Medicaid Markets

Elevance Stock Falls on Medicaid Concerns

Johnson & Johnson: Expiration of ACA subsidies won’t impact procedure demand

iX Biopharma Warrants See Strong Insider Take-Up, Funding U.S. Expansion

Celcuity announces FDA approval of Revtorpyk

HCA Says Florida Medicaid Approval Cushions 2Q

Caris Life Sciences expands prostate cancer offering with PTEN IHC testing

Shanxi's Shuozhou City Enhances Safety Oversight of Cold Chain Medical Equipment

Nexalis Therapeutics Options Expire Unexercised, Streamlining Capital Structure

Nexalis Therapeutics Issues Over 4.1 Million Unquoted Performance Rights

Aroa Biosurgery Welcomes CMS Plan to Keep Outpatient Skin Substitute Rates

BioArctic’s Partner Eisai Wins FDA Nod for At-Home Leqembi Injection in Early Alzheimer’s

Lakefront Biotherapeutics Board Member Resigns After Sanofi R&D Appointment

FICUS TECH Secures First Medical Device Purchase Order from Zhejiang Tianliang Biomedical Technology

Actinogen Medical Announces Employee Share Scheme Buy-Back

Yanji Authorities Conduct Quality and Safety Inspections on Dental Clinic Medical Equipment

Elevance and Unitedhealth Earnings are Next Test for Hot Health Insurer Stocks

Island Pharmaceuticals Issues Unquoted Options Under Employee Incentive Scheme

Wall Street Set for Record Investment Banking Fees Driven by SpaceX IPO and Mega-Deals

Is There a One-Time Medical Subsidy for Injured Workers Upon Retirement?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/RSPH/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RSPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","market":"US","secType":"STK","nameCN":"Invesco S&P 500 Equal Weight Health Care ETF","latestPrice":37.84,"timestamp":1788379200000,"preClose":37.47,"halted":0,"volume":518061,"hourTrading":{"tag":"盘后","latestPrice":37.8,"preClose":37.84,"latestTime":"19:58 EDT","volume":1087,"amount":41102.62,"timestamp":1788393528308,"change":-0.04,"changeRate":-0.001057,"amplitude":0.001057},"delay":0,"changeRate":0.009874566319722566,"floatShares":22250000,"shares":22250000,"eps":0,"marketStatus":"Closed","change":0.37,"latestTime":"09-02 16:00:00 EDT","open":37.52,"high":38.015,"low":37.52,"amount":19617878.515473,"amplitude":0.013211,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788422400000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":37.47,"sharesOutstanding":23410000,"nav":37.49609,"aum":849661399.4,"dividendRate":0.006134,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":37.47,"preClose":37.47,"latestTime":"08:10 EDT","volume":1,"amount":37.47,"timestamp":1788351018300,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":37.8,"preClose":37.84,"latestTime":"19:58 EDT","volume":1087,"amount":41102.62,"timestamp":1788393528308,"change":-0.04,"changeRate":-0.001057,"amplitude":0.001057},"volumeRatio":2.315195,"impliedVol":0.3468,"impliedVolPercentile":0.9802},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPH\",,,,,undefined,":{"symbol":"RSPH","floatShares":22250000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.315195,"shares":22250000,"dividePrice":0.2321,"high":38.015,"amplitude":0.013211,"preClose":37.47,"low":37.52,"week52Low":28.26,"pbRate":"--","week52High":38.19,"institutionHeld":0,"latestPrice":37.84,"eps":0,"divideRate":0.006134,"volume":518061,"delay":0,"ttmEps":0,"open":37.52,"prevYearClose":31.85,"prevWeekClose":37.44,"prevMonthClose":37.4,"prevQuarterClose":33.19,"fiveDayClose":37.84,"twentyDayClose":35.24,"sixtyDayClose":31.74},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RSPH\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"RSPH","amount":0.06267,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"RSPH","amount":0.05609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"RSPH","amount":0.05305,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"RSPH","amount":0.05991,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"},{"date":"2025-06-23","symbol":"RSPH","amount":0.05546,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"Invesco S&P 500 Equal Weight Health Care ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-27","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RSPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-30","value":0.198297,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-30","value":0.174967,"currency":"USD"},{"executeDate":"2023-06-20","recordDate":"2023-06-21","paymentDate":"2023-06-23","value":0.51083,"currency":"USD"},{"executeDate":"2023-09-18","recordDate":"2023-09-19","paymentDate":"2023-09-22","value":0.04794,"currency":"USD"},{"executeDate":"2023-12-18","recordDate":"2023-12-19","paymentDate":"2023-12-22","value":0.04988,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RSPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RSPH\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2651642464","title":"Elevance Plans to Exit More Medicaid Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2651642464","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651642464?lang=en_us&edition=fundamental","pubTime":"2026-07-15 23:00","pubTimestamp":1784127600,"startTime":"0","endTime":"0","summary":"1100 ET - Elevance Health says it is exiting more Medicaid markets. It recently reached an agreement with Washington, D.C., to leave the city's Medicaid market, and expects to exit more Medicaid markets over the next 12 to 18 months where it doesn't see a path to sustainable growth. The exits are part of Elevance's strategy to improve financial discipline and assess each market based on fit, operational requirements and the ability to generate good return on capital. Health insurers have been raising Medicaid rates to offset rising health costs. Elevance said it had fewer members in the most recent quarter, particularly in its Medicaid and Affordable Care Act plans. Shares drop 10%. Dow Jones NewswiresJuly 15, 2026 11:00 ET Copyright  2026 Dow Jones & Company, Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2505996509.AUD","LU0225283273.USD","LU0640476718.USD","SG9999004303.SGD","LU0208291251.USD","LU1548497426.USD","LU1023059063.AUD","LU1720051108.HKD","LU2244417387.USD","LU2357305700.SGD","LU2430703095.HKD","LU1506573853.SGD","LU0882574055.USD","IHF","LU0266013472.USD","LU0070302665.USD","LU0211331839.USD","LU2108987350.USD","SGXZ23171101.USD","LU0957791311.USD","LU0345770308.USD","LU1670628061.USD","LU1670627923.USD","LU2430703178.SGD","LU2237957902.USD","RSPH","LU1489326972.SGD","LU0314104364.USD","LU0048573561.USD","LU2505996681.GBP","SG9999003800.SGD","BK4588","LU0878866978.SGD","LU1057294990.SGD","LU0106261372.USD","LU0130517989.USD","LU0314106906.USD","LU0122379950.USD","LU0251142724.SGD","LU0289739699.SGD","ELV","LU2362541273.HKD","LU0320765489.SGD","LU0477156953.USD","LU0742534661.SGD","LU0251131958.USD","LU0648001328.SGD","BK4154","LU1720051017.SGD","LU0006306889.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651610004","title":"Elevance Stock Falls on Medicaid Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2651610004","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651610004?lang=en_us&edition=fundamental","pubTime":"2026-07-15 22:55","pubTimestamp":1784127300,"startTime":"0","endTime":"0","summary":"Skittish investors pushed Elevance shares down, as they focused on worries about its Medicaid business.CEO Gail Boudreaux said the insurer's Medicaid results were roughly what it expected, but the company is leaving the District of Columbia's Medicaid market and plans to exit others over the next year to 18 months. Under questioning from analysts, company officials wouldn't say how extensive those departures will be.Elevance shares were down 10% Wednesday, while competitors including Centene and Molina also slipped. The industry is under pressure from shrinking enrollment in Affordable Care Act plans and Medicaid.Elevance is seeing higher spending in areas including autism therapy, emergency-room use, outpatient surgery and specialty drugs.Elevance's second-quarter earnings beat Wall Street expectations, but its guidance for the full year was raised only modestly. The company reiterated that it expected 2026 to be the \"trough year\" for its Medicaid business's financial performance.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0557290698.USD","LU0314106906.USD","LU2430703251.USD","LU1244550494.USD","LU2264538146.SGD","LU1989771016.USD","MOH","IE0034235188.USD","IHF","CNCG","LU0122379950.USD","LU0058720904.USD","LU0795875169.SGD","LU1670628061.USD","LU2237957811.SGD","LU1074936037.SGD","LU0971096721.USD","LU1983299246.USD","LU0098860793.USD","IAI","LU2065170008.USD","LU0130518102.USD","LU2362541273.HKD","LU1064131342.USD","SG9999011175.SGD","LU1670627923.USD","ELV","BK4532","LU2347655156.SGD","SG9999014005.SGD","LU0882574055.USD","LU0648001328.SGD","SG9999014021.USD","SG9999014013.SGD","LU1668664300.SGD","LU0648000940.SGD","PSCH","SG9999003800.SGD","LU2111349929.HKD","BK4504","LU0314104364.USD","LU1162221912.USD","LU0251131958.USD","LU0106831901.USD","BK4154","CNC","RSPH","KBWB","LU0912757837.SGD","LU0048573561.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651667274","title":"Johnson & Johnson: Expiration of ACA subsidies won’t impact procedure demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2651667274","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651667274?lang=en_us&edition=fundamental","pubTime":"2026-07-15 21:26","pubTimestamp":1784121993,"startTime":"0","endTime":"0","summary":"Does not expect expiration of Affordable Care Act subsidies to materially impact demand for MedTech and procedures. Published first on TheFly – the...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/johnson-johnson-expiration-of-aca-subsidies-wont-impact-procedure-demand-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/johnson-johnson-expiration-of-aca-subsidies-wont-impact-procedure-demand-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4185","JDOC","IHE","BK4550","LU0210536198.USD","JNJ","LU2355687059.USD","MEDX","PJP","CURE","LU0433182093.SGD","LU1066051498.USD","LU1718418525.SGD","XLV","IE0002270589.USD","HCA","LU1066051811.HKD","SG9999014005.SGD","LU2112291526.USD","LU1674673428.USD","LU0289739699.SGD","LU0068578508.USD","LU2089984988.USD","RXL","LU0878866978.SGD","HUM","LU0274383776.USD","IHF","LU1244550577.SGD","IXJ","XHS","LU2403377893.USD","LU0792757196.USD","FHLC","LU2023250330.USD","LU0098860793.USD","LU0203347892.USD","ACA","GDOC","LU2129689514.USD","VHT","RSPH","FTXH","LU2505996681.GBP","LU0426412945.USD","LU1280957306.USD","BMED","IYH","FXH","LU1551013425.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651468729","title":"iX Biopharma Warrants See Strong Insider Take-Up, Funding U.S. Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2651468729","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651468729?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:08","pubTimestamp":1784117284,"startTime":"0","endTime":"0","summary":"The latest update is out from iX Biopharma Ltd. ( ($SG:42C) ). Singapore-based iX Biopharma Ltd. operates in the biopharmaceutical industry, focusi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/ix-biopharma-warrants-see-strong-insider-take-up-funding-u-s-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/ix-biopharma-warrants-see-strong-insider-take-up-funding-u-s-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PPH","GSKH","BK4209","RSPH","SG","SURI","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651655484","title":"Celcuity announces FDA approval of Revtorpyk","url":"https://stock-news.laohu8.com/highlight/detail?id=2651655484","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651655484?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:55","pubTimestamp":1784062511,"startTime":"0","endTime":"0","summary":"Celcuity (CELC) announced that the U.S. Food and Drug Administration approved REVTORPYK for the treatment of patients with hormone receptor positiv...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/celcuity-announces-fda-approval-of-revtorpyk-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/celcuity-announces-fda-approval-of-revtorpyk-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","SYNB","RSPH","BK4585","BBP","CELC","MRNX","FRTY","IYH","PSCH","PINK","LABU","BK4139","BMED","BK4588","MRNY","MEDI","GDOC","TECB","IBB","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105708","title":"HCA Says Florida Medicaid Approval Cushions 2Q","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105708","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105708?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:45","pubTimestamp":1784033100,"startTime":"0","endTime":"0","summary":"A regulatory win in Florida is providing HCA Healthcare with a timely offset to its payer mix pressures. The company recognized approximately $400 million in incremental net benefit from Medicaid Supplemental Payment Programs during the second quarter, the company said. The bulk of that stems from Florida's state-directed payment program, which the Centers for Medicare and Medicaid Services approved during the quarter. The benefit covers the period from Oct. 1, 2024, through June 30, 2026. HCA now expects Medicaid supplemental programs to contribute $300 million to $500 million for full-year 2026, compared with an earlier estimate of a $50 million to $250 million dragThis article was automatically created using artificial-intelligence technology and reviewed by Dow Jones Newswires editors. Dow Jones NewswiresJuly 14, 2026 08:45 ET Copyright  2026 Dow Jones & Company, Inc.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1084165304.USD","LU1150488218.USD","LU0068578508.USD","SG9999014021.USD","LU1119994496.HKD","LU1201861249.SGD","SG9999014005.SGD","LU0868494617.USD","BK4185","IE00B3S45H60.SGD","IHF","HCA","LU0878866978.SGD","LU1267930490.SGD","IE00B775SV38.USD","LU1267930573.SGD","LU2355687059.USD","SG9999014013.SGD","BK4504","BK4585","LU0211327993.USD","SG9999014039.USD","LU0310799852.SGD","LU0985489474.SGD","LU0187121727.USD","LU0708994859.HKD","LU1150488135.SGD","BK4588","LU1261432733.SGD","LU0648001328.SGD","LU0114720955.EUR","LU0882574055.USD","LU0211328371.USD","LU1489326972.SGD","LU0310800379.SGD","LU0130102774.USD","LU0433182093.SGD","LU0203345920.USD","RSPH","LU0029864427.USD","LU0203347892.USD","LU0128525929.USD","LU2244417387.USD","LU0980610538.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105407","title":"Caris Life Sciences expands prostate cancer offering with PTEN IHC testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105407","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105407?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:35","pubTimestamp":1784032510,"startTime":"0","endTime":"0","summary":"Caris Life Sciences (CAI) will offer in-house PTEN immunohistochemistry, or IHC, testing following the recent FDA approval of a biomarker-guided th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-expands-prostate-cancer-offering-with-pten-ihc-testing-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-expands-prostate-cancer-offering-with-pten-ihc-testing-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYNB","LFSC","BK4092","CAI","BK4588","IDNA","IYH","MRNX","BK4139","MRNY","MEDI","GDOC","PINK","FRTY","BK4585","IHC","BK4162","PSCH","BBP","RSPH","PTEN","BMED","IBB","LABU","TECB","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140004210","title":"Shanxi's Shuozhou City Enhances Safety Oversight of Cold Chain Medical Equipment","url":"https://stock-news.laohu8.com/highlight/detail?id=1140004210","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140004210?lang=en_us&edition=fundamental","pubTime":"2026-07-14 14:50","pubTimestamp":1784011838,"startTime":"0","endTime":"0","summary":"Authorities in Shuozhou City, Shanxi Province, have launched a targeted inspection initiative focusing on the management of cold chain systems within medical institutions and businesses involved in...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996","BK1583","RSPH","AGNG","HART","159883","MDEV","MEDX","BK1574","PTH","LGHT","BK1100","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651612476","title":"Nexalis Therapeutics Options Expire Unexercised, Streamlining Capital Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2651612476","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651612476?lang=en_us&edition=fundamental","pubTime":"2026-07-14 13:27","pubTimestamp":1784006857,"startTime":"0","endTime":"0","summary":"InhaleRx Limited ( ($AU:NX1) ) just unveiled an announcement. Nexalis Therapeutics Ltd, an ASX-listed biotechnology company trading under the ticke...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-options-expire-unexercised-streamlining-capital-structure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-options-expire-unexercised-streamlining-capital-structure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4007","FHLC","AGNG","XT","BK4588","BK4539","JDOC","BK4139","DARP","FWD","BBP","RSPH","LENZ","SYNB","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651247371","title":"Nexalis Therapeutics Issues Over 4.1 Million Unquoted Performance Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2651247371","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651247371?lang=en_us&edition=fundamental","pubTime":"2026-07-14 13:27","pubTimestamp":1784006835,"startTime":"0","endTime":"0","summary":"InhaleRx Limited ( ($AU:NX1) ) just unveiled an update. Nexalis Therapeutics Ltd is an Australian-listed biotechnology company focused on developin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-issues-over-4-1-million-unquoted-performance-rights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-issues-over-4-1-million-unquoted-performance-rights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGNG","FHLC","JDOC","BK4007","BK4585","LENZ","BK4588","IBB","DARP","FWD","XT","BK4139","BK4539","BBP","SYNB","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651140172","title":"Aroa Biosurgery Welcomes CMS Plan to Keep Outpatient Skin Substitute Rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2651140172","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651140172?lang=en_us&edition=fundamental","pubTime":"2026-07-14 08:08","pubTimestamp":1783987683,"startTime":"0","endTime":"0","summary":"Aroa Biosurgery Ltd ( ($AU:ARX) ) has shared an announcement. The United States Centers for Medicare & Medicaid Services has proposed keeping the c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aroa-biosurgery-welcomes-cms-plan-to-keep-outpatient-skin-substitute-rates?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aroa-biosurgery-welcomes-cms-plan-to-keep-outpatient-skin-substitute-rates?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CMS","LU0661504455.SGD","LU2346227817.USD","LU0553294199.USD","LU0949170772.SGD","LU1894683264.USD","LU1003077747.HKD","LU1894683348.USD","LU2500361329.USD","LU2637428348.USD","LU0545039389.USD","RSPH","BK4208","BK4585","BK4588","LU0738911758.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651422771","title":"BioArctic’s Partner Eisai Wins FDA Nod for At-Home Leqembi Injection in Early Alzheimer’s","url":"https://stock-news.laohu8.com/highlight/detail?id=2651422771","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651422771?lang=en_us&edition=fundamental","pubTime":"2026-07-14 06:08","pubTimestamp":1783980525,"startTime":"0","endTime":"0","summary":"BioArctic AB Class B ( ($SE:BIOA.B) ) has shared an update. BioArctic’s partner Eisai has secured U.S. FDA approval for Leqembi Iqlik, a once-weekl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bioarctics-partner-eisai-wins-fda-nod-for-at-home-leqembi-injection-in-early-alzheimers?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bioarctics-partner-eisai-wins-fda-nod-for-at-home-leqembi-injection-in-early-alzheimers?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4503","LU0441851309.USD","FRTY","IYH","LU2065170008.USD","MRNX","LU2360107671.USD","SG9999002679.SGD","RSPH","SG9999014492.USD","BMED","BK4585","LABU","PINK","LU0499858438.USD","MEDI","LU0516422366.SGD","BK4588","LU0532188223.SGD","LU0516423091.SGD","SG9999002414.USD","IE0031814969.USD","FDNI","LFSC","LU0823039010.USD","PSCH","LU2125910849.SGD","IBB","LU2152927971.USD","GDOC","LU2065171402.SGD","LU0589944569.HKD","LU0251143029.SGD","HBCP","BK4211","LU1861220207.SGD","MRNY","TECB","BBP","BK4535","BK4220","SG9999014484.SGD","SG9999013478.USD","IDNA","SG9999002406.SGD","SE","SG9999002620.SGD","SYNB","LU0516423174.USD","BK4554"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651144496","title":"Lakefront Biotherapeutics Board Member Resigns After Sanofi R&D Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2651144496","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651144496?lang=en_us&edition=fundamental","pubTime":"2026-07-14 04:57","pubTimestamp":1783976270,"startTime":"0","endTime":"0","summary":"Lakefront Biotherapeutics ( ($LKFT) ) has provided an update. Lakefront Biotherapeutics, a Belgium-based biotechnology company listed on Euronext a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lakefront-biotherapeutics-board-member-resigns-after-sanofi-rd-appointment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lakefront-biotherapeutics-board-member-resigns-after-sanofi-rd-appointment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","FWD","BK4007","XT","IBB","SYNB","BK4588","JDOC","RSPH","FHLC","DARP","SNYNF","AGNG","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149919620","title":"FICUS TECH Secures First Medical Device Purchase Order from Zhejiang Tianliang Biomedical Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=1149919620","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149919620?lang=en_us&edition=fundamental","pubTime":"2026-07-13 20:14","pubTimestamp":1783944876,"startTime":"0","endTime":"0","summary":"FICUS TECH (08107) has announced that a subsidiary of the group entered into an annual procurement framework agreement with Zhejiang Tianliang Biomedical Technology Co., Ltd. on July 9, 2026.The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGHT","RSPH","BK1100","HART","PTH","159883","GDOC","MEDX","BK4585","AGNG","BK1574","BK1583","BK1227","BK4581","BK4588","XBI","MDEV","08107","399441","09996","161726"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651019180","title":"Actinogen Medical Announces Employee Share Scheme Buy-Back","url":"https://stock-news.laohu8.com/highlight/detail?id=2651019180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651019180?lang=en_us&edition=fundamental","pubTime":"2026-07-13 15:38","pubTimestamp":1783928315,"startTime":"0","endTime":"0","summary":"Actinogen Medical ( ($AU:ACW) ) has provided an announcement. Actinogen Medical Ltd., an ASX-listed biotechnology company trading under the ticker ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-announces-employee-share-scheme-buy-back-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-announces-employee-share-scheme-buy-back-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","RSPH","JDOC","AGNG","BBP","XT","IBB","FHLC","SYNB","DARP","FWD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151111662","title":"Yanji Authorities Conduct Quality and Safety Inspections on Dental Clinic Medical Equipment","url":"https://stock-news.laohu8.com/highlight/detail?id=1151111662","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151111662?lang=en_us&edition=fundamental","pubTime":"2026-07-13 15:20","pubTimestamp":1783927251,"startTime":"0","endTime":"0","summary":"The Yanji Municipal Market Supervision Administration in Jilin Province has recently carried out targeted inspections on the quality and safety of medical devices used within dental clinics in its...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","RSPH","09996","BK1100","PTH","GDOC","MEDX","AGNG","159883","LGHT","BK1583","MDEV","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651196761","title":"Elevance and Unitedhealth Earnings are Next Test for Hot Health Insurer Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2651196761","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651196761?lang=en_us&edition=fundamental","pubTime":"2026-07-13 15:06","pubTimestamp":1783926364,"startTime":"0","endTime":"0","summary":"After a rocky start to the year, health insurer stocks have roared back. But the big test comes this week, when the companies begin to report second quarter earnings.The insurers are trying to end a d","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNCG","HRTS","LU0130517989.USD","UNHG","LU1035773651.USD","BK4154","LU1093756325.SGD","LU1854104046.USD","CNC","LU0097036916.USD","LU0128525689.USD","UNHW","IE00B1BXHZ80.USD","LU0553294199.USD","LU0965509101.SGD","RTH","XLV","CVS","LU0820561818.USD","RXL","IE0004086264.USD","HUM","IE0004445015.USD","UNH","LU1854103824.USD","SG9999017495.SGD","LU0158827948.USD","BK4196","XHS","LU1814569148.SGD","IE0034235188.USD","LU2362541273.HKD","LU2125154935.USD","LU2279689827.SGD","LU0310800965.SGD","LU1778281490.HKD","SGXZ81514606.USD","GDOC","RSPH","LU0006061336.USD","LU1732800096.USD","BK4581","GSX","LU2244417387.USD","ELV","LU1119994496.HKD","IHF","IYH","LU2133065610.SGD","LU0106831901.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651196208","title":"Island Pharmaceuticals Issues Unquoted Options Under Employee Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2651196208","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651196208?lang=en_us&edition=fundamental","pubTime":"2026-07-13 14:33","pubTimestamp":1783924409,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals Ltd ( ($AU:ILA) ) has provided an announcement. Island Pharmaceuticals Ltd is an Australian-listed biotechnology company foc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/island-pharmaceuticals-issues-unquoted-options-under-employee-incentive-scheme?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/island-pharmaceuticals-issues-unquoted-options-under-employee-incentive-scheme?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGNG","RSPH","BK4585","SYNB","BK4588","FHLC","DARP","BBP","IBB","JDOC","FWD","XT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121454054","title":"Wall Street Set for Record Investment Banking Fees Driven by SpaceX IPO and Mega-Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=1121454054","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121454054?lang=en_us&edition=fundamental","pubTime":"2026-07-13 14:21","pubTimestamp":1783923670,"startTime":"0","endTime":"0","summary":"Major Wall Street banks are poised to report their highest investment banking fee revenue in four and a half years this week, fueled by the landmark SpaceX initial public offering and a resurgence in...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPCF","FAZ","BK4089","CANC","PSP","RSPH","SNK","XOVR","BK4615","BK4585","SPCG","LQPE","IYH","UFO","SPCH","LOFF","MNA","IBBQ","FFSM","DXYZ","VXF","IPO","BK4588","ACTV","SPAL","SPAX","QQQS","SPCX","UYG","PEVC","SPCM","SPCQ","SSPC","SPCK","RFG","SPCU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176573492","title":"Is There a One-Time Medical Subsidy for Injured Workers Upon Retirement?","url":"https://stock-news.laohu8.com/highlight/detail?id=1176573492","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176573492?lang=en_us&edition=fundamental","pubTime":"2026-07-12 11:40","pubTimestamp":1783827656,"startTime":"0","endTime":"0","summary":"Workers who have sustained occupational injuries may be eligible to receive a lump-sum medical subsidy upon reaching retirement age, depending on the specific circumstances and applicable...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0070302665.USD","SG9999014021.USD","LU0208291251.USD","LU0417517546.SGD","RSPH","LU0211331839.USD","BK4533","IHF","BK4566","LU1983260115.SGD","FXH","HUM","LU0238689110.USD","LU0348723411.USD","LU0390134368.USD","SG9999014013.SGD","LU0170899867.USD","LU0266013472.USD","BK4585","LU0256863811.USD","BK4588","LU1093756325.SGD","BK4154","LU0320765489.SGD","SG9999014005.SGD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":8,"totalSize":176,"code":"91000000","status":"200"}]}}